Nanoviricides (NNVC) Return on Assets [ROA] (2011 - 2026)
Nanoviricides' Return on Assets [ROA] was -82.68% in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 19.06 percentage points from -101.74% a year earlier but down 9.96 percentage points from the prior quarter.
Powered by 
Analysis
Nanoviricides (NNVC) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Return on Assets [ROA] at Nanoviricides came in at -88.85%, down 0.23 percentage points from FY2025.
- Return on Assets [ROA] has now declined for four consecutive fiscal years, with a five-year change of -56.28 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Assets [ROA] was -88.62% in FY2025 (-30.98 pp), -57.64% in FY2024 (-13.35 pp), -44.29% in FY2023 (-14.12 pp) and -30.16% in FY2022 (+2.41 pp).
- Quarterly Return on Assets [ROA] has moved between -101.74% (fiscal Q4 2025) and -30.70% (fiscal Q1 2022) over five years.
- Compared with a year earlier, Return on Assets [ROA] has increased for three straight quarters, with an average year-over-year change of -7.73 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was fiscal Q1 2022 (a gain of 20.22 percentage points); the worst was fiscal Q3 2024 (a drop of 43.49 percentage points).
- Per Business Quant data, NNVC's Return on Assets [ROA] in the three fiscal quarters before Q4 2026 was -72.72% (Q3 2026), -81.40% (Q2 2026) and -95.69% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 2.14% |
| 10 | Nanoviricides | 28.26 Mn | 15.92 Mn | - | -82.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -82.68% |
| Mar 31, 2026 | -72.72% |
| Dec 31, 2025 | -81.40% |
| Sep 30, 2025 | -95.69% |
| Jun 30, 2025 | -101.74% |
| Mar 31, 2025 | -91.36% |
| Dec 31, 2024 | -81.74% |
| Sep 30, 2024 | -78.70% |
| Jun 30, 2024 | -69.72% |
| Mar 31, 2024 | -78.43% |
| Dec 31, 2023 | -66.25% |
| Sep 30, 2023 | -56.27% |
| Jun 30, 2023 | -49.02% |
| Mar 31, 2023 | -34.94% |
| Dec 31, 2022 | -32.48% |
| Sep 30, 2022 | -31.00% |
| Jun 30, 2022 | -33.33% |
| Mar 31, 2022 | -32.34% |
| Dec 31, 2021 | -31.13% |
| Sep 30, 2021 | -30.70% |
API Access
Nanoviricides Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();